Supplementary Data S1 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics

<p>Includes a large list of all the peptides and details of the HLA-I ligands identified at <=0.01 FDR and >=30 ALC score</p>

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Maria Lozano-Rabella (15056515) (author)
مؤلفون آخرون:	Andrea Garcia-Garijo (15056518) (author), Jara Palomero (15056521) (author), Anna Yuste-Estevanez (15056524) (author), Florian Erhard (15056527) (author), Roc Farriol-Duran (15056530) (author), Juan Martín-Liberal (15056533) (author), Maria Ochoa-de-Olza (15056536) (author), Ignacio Matos (15056539) (author), Jared J. Gartner (15046103) (author), Michael Ghosh (15056542) (author), Francesc Canals (15056545) (author), August Vidal (15056548) (author), Josep Maria Piulats (15056551) (author), Xavier Matías-Guiu (15056554) (author), Irene Brana (15056557) (author), Eva Muñoz-Couselo (14957498) (author), Elena Garralda (15039090) (author), Andreas Schlosser (15056560) (author), Alena Gros (15056563) (author)
منشور في:	2025
الموضوعات:	Cancer Therapeutic Research and Development Immuno-oncology Immunology Immune responses to cancer Tumor antigens/neoantigens Immunotherapy Cancer vaccines Cellular immunotherapy Translational Research
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة